BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14504423)

  • 1. Current attitudes to the therapy of vasculitis.
    Jayne D
    Kidney Blood Press Res; 2003; 26(4):231-9. PubMed ID: 14504423
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive treatment for vasculitis associated with Lyme borreliosis.
    Komdeur R; Zijlstra JG; van der Werf TS; Ligtenberg JJ; Tulleken JE
    Ann Rheum Dis; 2001 Jul; 60(7):721. PubMed ID: 11436861
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis.
    Levine SM
    Ann Intern Med; 2010 Jan; 152(1):65; author reply 65. PubMed ID: 20048281
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
    Lapraik C; Watts R; Bacon P; Carruthers D; Chakravarty K; D'Cruz D; Guillevin L; Harper L; Jayne D; Luqmani R; Mooney J; Scott D;
    Rheumatology (Oxford); 2007 Oct; 46(10):1615-6. PubMed ID: 17804455
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
    N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy in autoimmune disease: vasculitis.
    Carruthers D; Bacon P
    Springer Semin Immunopathol; 2001; 23(1-2):91-108. PubMed ID: 11455864
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasculitis: clinical approach, pathophysiology and treatment.
    Kallenberg CG
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):656-9. PubMed ID: 11020951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANCA-associated vasculitis: diagnosis and treatment in the elderly.
    Parry R; Sherwin S; Fletcher V; Medcalf P
    Postgrad Med J; 1996 Jul; 72(849):423-6. PubMed ID: 8935603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vasculitis and diabetes insipidus, reversible by administration of cyclophosphamide].
    Mallet H; Dupond JL
    Presse Med; 1995 Nov; 24(36):1709. PubMed ID: 8545406
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of chronic hepatitis C virus infection by cyclophosphamide in a patient with cANCA-positive vasculitis.
    Arend SM; Hagen EC; Kroes AC; Bruijn JA; van der Woude FJ
    Nephrol Dial Transplant; 1995; 10(6):884-7. PubMed ID: 7566624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy of vasculitis with immunosuppressive agents, immunomodulators and cyclosporin A].
    Abe C
    Nihon Rinsho; 1985 Oct; 43(10):2196-9. PubMed ID: 3912547
    [No Abstract]   [Full Text] [Related]  

  • 13. L44. Management of relapses in vasculitis.
    Mouthon L
    Presse Med; 2013 Apr; 42(4 Pt 2):619-22. PubMed ID: 23477710
    [No Abstract]   [Full Text] [Related]  

  • 14. [The therapy of vasculitis].
    Andrassy K; Waldherr R; Hergesell O; Ritz E
    Dtsch Med Wochenschr; 1996 Aug; 121(31-32):985-7. PubMed ID: 8765402
    [No Abstract]   [Full Text] [Related]  

  • 15. [New strategies in diagnosis and therapy of vasculitides].
    Stierle HE
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():143-6. PubMed ID: 16802540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necrotizing vasculitis--a 2009 update.
    Sharaf PH; Yazici Y
    Bull NYU Hosp Jt Dis; 2009; 67(3):303-5. PubMed ID: 19852754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ANCA-associated vasculitis.
    Langford CA
    N Engl J Med; 2003 Jul; 349(1):3-4. PubMed ID: 12840085
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Sanders JS; Slot MC; Stegeman CA
    N Engl J Med; 2003 Nov; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795
    [No Abstract]   [Full Text] [Related]  

  • 19. L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
    Hoffman GS
    Presse Med; 2013 Apr; 42(4 Pt 2):643-50. PubMed ID: 23474045
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.